HepaStem Long-Term Safety Registry
NCT03343756 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2024-05-29
Summary
All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Biosciences
Conditions
- Urea Cycle Disorder
- Crigler-Najjar Syndrome
- Acute on Chronic Liver Failure
Sponsors & Collaborators
-
Cellaion SA
lead INDUSTRY
Eligibility
- Min Age
- 5 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-04
- Primary Completion
- 2024-05-23
- Completion
- 2024-05-23
Countries
- Belgium
- Bulgaria
- France
- Poland
- Spain
Study Locations
More Related Trials
-
Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)
NCT02523196 ·Status: COMPLETED ·Phase: PHASE3
-
MRG-001 in Patients With Alcoholic Hepatitis
NCT06307522 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
International Alfapump Cohort Study
NCT04326946 ·Status: ACTIVE_NOT_RECRUITING
-
Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units
NCT01079104 ·Status: TERMINATED ·Phase: NA
-
Sensitivity of Alternative NRL972 Detection Methods in Healthy Subjects
NCT01164332 ·Status: COMPLETED ·Phase: PHASE1
-
RAI & HRS: Relationship Between Relative Adrenal Insufficiency and Failure of Treatment in Hepatorenal Syndrome
NCT04273750 ·Status: COMPLETED
-
hepatomiR cACLD Study
NCT06432582 ·Status: RECRUITING
-
The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure
NCT00655304 ·Status: COMPLETED ·Phase: NA
-
Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using Thromboelastography
NCT02757170 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic Patients
NCT02356250 ·Status: WITHDRAWN
-
Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy
NCT05124041 ·Status: COMPLETED ·Phase: NA
-
Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units
NCT01079091 ·Status: TERMINATED ·Phase: NA
-
Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
NCT03171727 ·Status: UNKNOWN ·Phase: NA
-
To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.
NCT02465619 ·Status: WITHDRAWN
-
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
NCT06855056 ·Status: RECRUITING
-
Unknown Cause of Acute Liver Failure
NCT02041637 ·Status: COMPLETED
-
Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)
NCT01151475 ·Status: COMPLETED
-
Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
NCT00252642 ·Status: COMPLETED ·Phase: NA
-
Acute hemodynamiC Response To Carvedilol Predicts Survival in ACLF Patients
NCT06298656 ·Status: NOT_YET_RECRUITING
-
Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"
NCT01201720 ·Status: COMPLETED ·Phase: NA
-
Portal Hypertension and Systemic Endothelial Function
NCT02850692 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure
NCT03084198 ·Status: UNKNOWN ·Phase: NA
-
Velacur by Sonic Incytes for Portal Hypertension
NCT04576897 ·Status: COMPLETED ·Phase: NA
-
Vienna Vascular Liver Disease Study
NCT03541057 ·Status: RECRUITING
-
Chronic Liver Disease in Urea Cycle Disorders
NCT03721367 ·Status: COMPLETED